Skip to main content
Thor Medical ASA logo

Thor Medical ASA — Investor Relations & Filings

Ticker · NANOV ISIN · NO0010597883 LEI · 5967007LIEEXZXG6DK30 OL Manufacturing
Open in API
Filings indexed 106 across all filing types
Latest filing 2025-12-23 Regulatory Filings
Country NO Norway
Listing OL NANOV

About Thor Medical ASA

https://www.thormedical.com/

Thor Medical ASA is a producer and supplier of alpha-particle emitters for cancer therapy. The company specializes in manufacturing isotopes, such as Thorium-228, by separating decay products from naturally occurring Thorium-232. This is achieved through a proprietary production technology that offers high efficiency, cost-competitiveness, and superior environmental friendliness. The company provides these critical alpha-emitters to partners developing next-generation targeted alpha therapies for precision oncology.

Recent filings

Filing Released Lang Actions
Thor Medical reaches key construction milestones at AlphaOne plant
Regulatory Filings Classification · 95% confidence The document is a press release issued by Thor Medical ASA regarding construction milestones at their AlphaOne plant. It does not contain financial statements, regulatory filings, or specific corporate governance disclosures. As it is a general corporate update regarding operational progress and does not fit into the specific categories like M&A, earnings, or board changes, it falls under the general regulatory/press release category.
2025-12-23 English
RadioMedix and Thor Medical enter supply agreement for thorium-228 - Attachment: Download announcement as PDF.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a commercial supply agreement between Thor Medical ASA and RadioMedix. It does not fit into specific financial reporting categories like 10-K, ER, or IR. Since it is a general corporate announcement regarding business operations and partnerships that does not fall into the other specialized categories, it is classified as a Regulatory Filing (RNS).
2025-12-04 English
RadioMedix and Thor Medical enter supply agreement for thorium-228
Regulatory Filings Classification · 90% confidence The document is a press release announcing a commercial supply agreement between Thor Medical ASA and RadioMedix. It describes a business partnership rather than a financial report, governance update, or regulatory filing. Since it does not fit into specific categories like M&A (which usually implies a merger or acquisition of the company itself) or capital updates, and it is a general corporate announcement, it falls under the 'Regulatory Filings' (RNS) category as a fallback for miscellaneous corporate news.
2025-12-04 English
Thor Medical ASA - New share capital registered - Attachment: Download announcement as PDF.pdf
Share Issue/Capital Change Classification · 95% confidence The document is a short announcement (1487 characters) about the registration of new share capital following a share issuance under a restricted share units program. It references a previous stock exchange announcement and provides updated share capital details. There are no financial statements or detailed financial data, only a regulatory disclosure about capital changes. The document fits the category of a Share Issue/Capital Change announcement rather than a full financial report or other filing types.
2025-11-20 Norwegian
Thor Medical ASA - New share capital registered
Share Issue/Capital Change Classification · 100% confidence The document announces the registration of new share capital following a previously announced issuance of shares related to a restricted share units program. It explicitly mentions the new share capital amount and the total number of shares. This falls under the category of share capital changes or new share issues.
2025-11-20 English
Thor Medical enters supply agreement with NucliThera for thorium-228 - Attachment: Download announcement as PDF.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a supply agreement between Thor Medical ASA and NucliThera AS for thorium-228. It contains no financial statements, regulatory form references, or detailed financial data. The length is under 5,000 characters and it is a non-regulatory press release about a business agreement. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Capital/Financing Update. It is not a regulatory filing or certification. The content is best classified as a general regulatory announcement or miscellaneous filing that does not fit other categories, which corresponds to Regulatory Filings (RNS).
2025-11-20 Norwegian

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.